Publications by authors named "Evgenia I Sluchanko"
Article Synopsis
- Metformin is commonly used to treat type 2 diabetes, but individual responses to the drug can vary significantly, potentially due to genetic differences.
- A study analyzed the effects of specific genetic variants on metformin response in 299 patients, identifying the rs12208357 variant as significantly impacting treatment outcomes.
- Machine learning models incorporating genetic and clinical factors, like gender and body measurements, were developed to better predict metformin response, showing potential for personalized diabetes treatment approaches.
